BOCIC(SH:601696) Xin Lang Cai Jing·2025-09-11 02:21Group 1 - The stock of Zhixiang Jintai fell by 5.61% on September 11, closing at 31.80 CNY per share, with a trading volume of 31.83 million CNY and a turnover rate of 0.84%, resulting in a total market capitalization of 11.66 billion CNY [1] - Zhixiang Jintai, established on October 20, 2015, and listed on June 20, 2023, is primarily engaged in the research, production, and sales of antibody drugs, with 99.96% of its revenue coming from drug sales [1] Group 2 - According to data, a fund under Bank of China Securities holds a significant position in Zhixiang Jintai, with the Bank of China Health Industry Mixed Fund (002938) owning 255,000 shares, accounting for 4.48% of the fund's net value, making it the eighth largest holding [2] - The Bank of China Health Industry Mixed Fund was established on September 7, 2016, with a current size of 158 million CNY, and has achieved a year-to-date return of 59.36%, ranking 357 out of 8175 in its category [2] - The fund manager, Li Mingwei, has been in charge for 2 years and 203 days, with the best and worst fund returns during his tenure both recorded at 7.32% [2]